Martin Desrosiers

Centre Hospitalier de l’Université de Montréal — Canada

Medicine · Health Sciences

8h-index957citations19works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sinusitis and nasal conditions(12), Allergic Rhinitis and Sensitization(7), Nasal Surgery and Airway Studies(7), Asthma and respiratory diseases(4), Head and Neck Surgical Oncology(3)

Publications19 total

Efficacy of tezepelumab in adults with severe, uncontrolled chronic rhinosinusitis with nasal polyps and comorbid NSAID-exacerbated respiratory disease (WAYPOINT)
2025
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
The Lancet·2025· 40 cited
High-Throughput RNA Sequencing Enables Hypothesis-Free Pathogen Identification in Primary Nasal Epithelial Cells
Journal of Allergy and Clinical Immunology·2025Open Access
Mapping the Epigenetic Signatures in Nasal Cells Provides Insights into the Pathogenesis of Chronic Rhinosinusitis
Journal of Allergy and Clinical Immunology·2025Open Access
Response to “Letter to the Editor”; Liao and Kern
International Forum of Allergy & Rhinology·2024Open Access
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps
Current Allergy and Asthma Reports·2024· 12 citedOpen Access
Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP
International Forum of Allergy & Rhinology·2024· 8 citedOpen Access
NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry
Laryngo-Rhino-Otologie·2024
Utilization of Transcriptomic Profiling to Identify Molecular Markers Predicting Successful Recovery Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis
Otolaryngology·2023· 3 citedOpen Access
Azithromycin Mechanisms of Action in CRS Include Epithelial Barrier Restoration and Type 1 Inflammation Reduction
Otolaryngology·2023· 6 cited
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
Journal of Patient-Reported Outcomes·2023· 14 citedOpen Access
INTRANASAL APPLICATION OF <i>LACTOCOCCUS LACTIS W 136</i> BACTERIA EARLY IN SARS-Cov-2 INFECTION MAY HAVE A BENEFICIAL IMMUNOMODULATORY EFFECT: A PROOF-OF-CONCEPT STUDY
2021· 4 cited
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine·2021· 531 citedOpen Access
Reducing Fungal Exposure Critical for Treating Rhinosinusitis with or without Polyps [Response to Letter]
Journal of Asthma and Allergy·2021· 2 citedOpen Access
Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps
Journal of Asthma and Allergy·2021· 248 citedOpen Access
Brave New (Microbial) World: implications for nasal and sinus disorders
Brazilian Journal of Otorhinolaryngology·2019· 8 citedOpen Access
Type 2 Inflammation Plays a Critical Role in Pathophysiology of CRS
Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)·2019Open Access
Evaluation of the Nasal Response to Histamine Provocation with Acoustic Rhinometry
The Journal of Otolaryngology·2001· 8 cited
Impact of Rhinosinusitis in Health Care Delivery: The Quebec Experience
The Journal of Otolaryngology·2001· 73 cited

Frequent Co-authors

Stella E. Lee(5), Audrey Pelletier(5), Léandra Mfuna Endam(5), Wytske J. Fokkens(4), Emmanuel González(4), Damien Adam(4), Emmanuelle Brochiero(4), Joseph K. Han(3), Claus Bachert(3), Ana R. Sousa(3), Achim G. Beule(3), Ludger Klimek(3), Jorge Máspero(3), Eugenio De Corso(3), Claire Hopkins(3), Fabiana Cardoso Pereira Valera(3), Martin Wagenmann(2), Bhabita Mayer(2), Robert Chan(2), Cecilia Ahlström Emanuelsson(2)